Injecto Polymers IPO Day 2: GMP ₹0

Welcome back, investors! We’re diving into the second day of the Injecto Polymers SME IPO subscription on the BSE. As of the end of Day 2, the IPO remains completely un-subscribed across all categories. This means that not a single share has been applied for by Retail, High Net-worth Individuals (HNIs), or Qualified Institutional Buyers (QIBs) yet. It’s a quiet start, to say the least, and we’ll be dissecting what this means for your investment decisions.

Subscription Status

Let’s break down the subscription numbers for Injecto Polymers on Day 2. We’re looking at a flat zero across the board: Retail investors have subscribed 0x, Non-Institutional Investors (NIIs) are at 0x, and Qualified Institutional Buyers (QIBs) are also at 0x. Consequently, the total subscription stands at a flat 0x. This is an unusual situation for any IPO, especially one with a lot size of 1200 shares and an issue price of ₹100. Typically, by the second day, we’d expect to see at least some interest, even if it’s just a modest fraction. The complete lack of subscription could be concerning for potential investors, as it suggests a lack of immediate demand. It’s important to remember that the IPO period runs until September 16, 2026, so there’s still time for interest to build. However, this initial lull is definitely something to keep an eye on.

GMP Update

Now, let’s talk about the Grey Market Premium (GMP). For Injecto Polymers, the current GMP is ₹0. Yesterday, the GMP was also reported at ₹0. This stagnation at zero indicates that, in the unofficial market, there’s no premium being offered for Injecto Polymers shares over its issue price of ₹100. The expected listing price remains at ₹100, mirroring the issue price. A GMP of ₹0 isn’t necessarily a death knell, but it certainly doesn’t paint a picture of overwhelming market enthusiasm. It suggests that the market is currently neutral on the company’s prospects post-listing, or perhaps it’s too early for significant price discovery in the grey market. We’ll need to see if the GMP starts to move in the coming days to gauge investor sentiment better.

Should You Apply?

This is the million-dollar question, isn’t it? Based on the current data, Injecto Polymers is presenting a very cautious picture. The complete lack of subscription on Day 2, coupled with a flat ₹0 GMP, suggests that immediate demand is extremely low. While there’s still time left in the IPO window, this initial lack of interest could be a red flag for many. Typically, a healthy subscription level, especially in the Retail and NII categories, and a positive GMP are good indicators of post-listing performance. However, it’s also true that SME IPOs can sometimes see a surge in interest towards the closing days. The SEBI advisor’s guidance always emphasizes thorough due diligence. You’ll want to look beyond just the subscription numbers and GMP. Consider the company’s fundamentals, its business model, future growth prospects, and the management’s track record. If you’re a risk-averse investor, this IPO might warrant a wait-and-watch approach. For those with a higher risk appetite and a belief in the company’s long-term potential, a small application might be considered, but only after careful research. The bottom line is, proceed with caution and make an informed decision based on your own investment goals and risk tolerance. You can View Full Injecto Polymers IPO Details for more comprehensive information.